Netherlands· NL-70693e22be16
Clobazam Aurobindo 10 mg, tabletten
A clobazam product containing clobazam, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Clobazam is registered in 17 of 19 countries.
Countries holding a registration under ATC N05BA09 (clobazam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Clobazam · ATC N05BA09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clobazam costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.15 in France to $1.05 in Switzerland — a ×7.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clobazam · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.05
- ES Spain$0.29
- FR France$0.15
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CLOBAZAM
- Manufacturer
- Aurobindo Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- N05BA09
- ATC class
- Clobazam
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129895
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
206 interactions on record for clobazam.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clobazam · interactions on record
206 records
- 5 severe
- 132 moderate
- 19 minor
Most severe, free to view
- EliglustatA16AX10severe
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clobazam in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomClobazam 10mg tabletsDE Pharmaceuticals
- United StatesClobazamMicro Labs Limited
- PolandFrisium 10InPharm Sp. z o.o.
- NorwayFrisiumAtnahs
- CanadaAPO-CLOBAZAMAPOTEX INC
- IrelandClobazam Brown & Burk 10mg TabletsBrown & Burk IR Limited
- CzechiaFRISIUMSanofi s.r.o., Praha
- FranceURBANYL 10 mg, comprimé sécableATNAHS PHARMA FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Clobazam Essential Pharmaceuticals
- Belgium · Clobazam Essential Pharmaceuticals, Frisium
- Cyprus · Frisium
- Czechia · Frisium
- Germany · Clobazam Desitin, Clobazam Micro Labs
- Denmark · Clobazam Brown & Burk Ir Limited, Clobazam Essential Pharmaceuticals
- Spain · Noiafren, Silocalm
- Finland · Clobazam Essential Pharmaceuticals
- France · Likozam, Urbanyl
- United Kingdom (Northern Ireland) · Clobazam, Clobazam Accord
- Greece · Frisium
- Hungary · Frisium
- Ireland · Clobazam Brown & Burk, Clobazam Essential Pharmaceuticals
- Italy · Epaclob, Frisium
- Luxembourg · Clobazam Essential Pharmaceuticals, Frisium
- Malta · Clobazam Atnahs, Clobazam Burk
- Norway · Clobazam Essential Pharmaceuticals
- Poland · Frisium
- Portugal · Castilium, Clobazam Generis
- Slovenia · Klobazam Burk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2c05b195-afe3-4bb0-bb9f-319e7a566623 GET /v1/drugs/2c05b195-afe3-4bb0-bb9f-319e7a566623?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129895_smpc.pdf",
"strength": null,
"atc_label": "Clobazam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129895",
"excipients": [
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)"
],
"substances": [
"CLOBAZAM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129895.pdf",
"authorised_at": "2023/05/08",
"procedure_number": "PT/H/2549/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "129895",
"additional_monitoring": "N"
}See everything about clobazam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.